サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：副鼻腔拡張装置の世界市場-2022-2029
市場調査レポート
商品コード
1153817

副鼻腔拡張装置の世界市場-2022-2029

Global Sinus Dilation Devices Market - 2022-2029
出版日: | 発行: DataM Intelligence | ページ情報: 英文 200 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
副鼻腔拡張装置の世界市場-2022-2029
出版日: 2022年11月15日
発行: DataM Intelligence
ページ情報: 英文 200 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

市場の概要

副鼻腔拡張装置の世界市場は、2021年に35億1,643万米ドルとなり、2029年には49億8,372万米ドルに達すると予測され、予測期間（2022～2029年）の年平均成長率は5.07%となっています。

副鼻腔感染症は、鼻腔や副鼻腔の腫れを伴うもので、副鼻腔炎としても知られています。副鼻腔拡張装置は、副鼻腔疾患の外科的治療に使用されています。副鼻腔拡張装置は、副鼻腔疾患の外科的治療に使用され、慢性副鼻腔炎患者において良好な結果が得られたことから、近年、その普及が進んでいます。慢性副鼻腔炎は、世界的に大きな問題となっています。

市場力学

慢性副鼻腔炎の有病率の増加、医療用拡張装置の規制認可の増加、低侵襲手術の採用、研究開発の継続が、予測期間中の副鼻腔拡張装置の世界市場を牽引しています。

新製品発売の増加や研究開発の高まりが市場成長の原動力となります。

副鼻腔拡張装置の世界市場は、主に慢性副鼻腔炎の高い有病率と低侵襲手術への嗜好の高まりによって駆動されています。また、新興国での医療費助成制度が充実していることも、市場拡大の要因となっています。

副鼻腔炎治療における技術的進歩や、従来の手術に対するバルーン副鼻腔拡張の利点は、世界の副鼻腔拡張装置市場に貢献しています。例えば、2022年2月に、ヘルスケアテクノロジー企業のMedtronic Plcは、米国FDAによって承認されたNuVentという名前の新しい耳管拡張バルーンを発売しました。NuVentは、外科医が適切なオフィスまたは外来患者設定の治療を提供するのに役立ちます。このバルーンは、患者の解剖学的構造に基づき、設置場所をカスタマイズすることができます。

様々な資金調達、斬新な技術の進歩、最新の革新的な製品の発売数が増加しており、副鼻腔拡張デバイスの高い需要に繋がっています。例えば、2021年9月、低侵襲性ENT技術を設計するAcclarent Inc, Johnson &Johnson Medical Device Subsidiaryは、手術計画を簡素化し、ENTナビゲーション処置中に、フィードバックを与えるAI搭載ENT技術を発表しました。このソフトウェアは、TruPathとTruSegをTruDiナビゲーションシステムと併用し、内視鏡下副鼻腔手術などのENT手術において効率的な画像誘導によるナビゲーションとプランニングを提供する予定です。

副鼻腔拡張装置に関連する代替品の存在と高コストが市場成長の妨げとなります。

しかし、副鼻腔拡張装置に関連する高コストや、副鼻腔炎治療薬による副鼻腔外科手術への嗜好性の低さが、市場の進展を阻害する可能性があります。市販薬は費用の多くを占めるが、慢性副鼻腔炎患者のほとんどに最小限の利益をもたらします。

COVID-19の影響分析

パンデミックは、世界の財務予測、オペレーション、危機対応戦略にマイナスの影響を及ぼしています。COVID-19の発生は、ヘルスケア産業に深刻な影響を及ぼしています。副鼻腔拡張装置市場は、COVIDに注意が向けられたためにすべての研究や臨床試験に影響が及び、莫大な損失を経験しました。しかし、現在、市場参入企業は、研究市場を活用し、パンデミックに対抗するために最先端のアイテムを作成することによって、長期的および短期的な成長戦略を変えています。様々な取り組み、コラボレーション、合併が世界中で起こっており、市場の成長を後押ししています。例えば、2020年7月、独自の内視鏡メーカーであるOptim LLCは、同社のENTity Nasopharyngoscopesを世界の恵まれないコミュニティに寄付するためのMedShareとの提携を発表しました。

目次

第1章 市場調査手法とスコープ

  • 調査手法
  • 調査目的および調査範囲

第2章 市場の定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 市場影響要因
    • 促進要因
      • 新製品上市の増加
      • 研究開発の増加
    • 抑制要因
      • 市場で入手可能な代替品
    • ビジネスチャンス
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース
  • アンメットニーズ
  • サプライチェーン分析
  • 規制分析

第6章 COVID-19分析

  • COVID-19の市場分析
    • COVID-19以前の市場シナリオ
    • COVID-19の現在の市場シナリオ
    • COVID-19の後、または将来のシナリオ
  • COVID-19の中での価格ダイナミクス
  • 需要-供給スペクトラム
  • パンデミック時の市場に関連する政府の取り組み
  • メーカーの戦略的取り組み
  • まとめ

第7章 製品別

  • バルーンサイナス・ダイレーションデバイス
  • サイナス・スコープ
  • 鼻腔鏡
  • ハンドヘルド機器
  • サイナス・ステント

第8章 施術タイプ別

  • スタンドアロン副鼻腔拡張
  • ハイブリッド副鼻腔拡張

第9章 エンドユーザー別

  • 病院
  • 外来外科センター
  • 耳鼻咽喉科クリニック
  • その他

第10章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他の南米地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ地域

第11章 競合情勢

  • 主な展開と戦略
  • 企業シェア分析
  • 製品ベンチマーク
  • 注目の主要企業リスト

第12章 企業プロファイル

  • Medtronic Plc
    • 企業概要
    • 製品ポートフォリオと説明
    • 主なハイライト
    • 財務概要
  • Smith and Nephew Plc
  • Acclarent, Inc.
  • Stryker
  • Olympus Corporation
  • Optim LLC
  • Cook Medical
  • Summit Health Medical
  • Dalent Medical
  • Meril Life Sciences

第13章 副鼻腔拡張装置の世界市場-DataM

目次
Product Code: DMMD883

Market Overview

The global sinus dilation devices market was valued at US$ 3,516.43 million in 2021 and is estimated to reach US$ 4,983.72 million by 2029, growing at a CAGR of 5.07% during the forecast period (2022-2029).

Sinus infection involves swelling of nasal passages or sinuses, also known as sinusitis. Sinus dilation devices are used in the surgical treatment of sinus disease. The satisfactory results of these devices in patients with chronic sinusitis have increased their adoption in recent years. Chronic sinusitis and related conditions are a dominant medical problem worldwide.

Market Dynamics

Increased prevalence of chronic sinusitis, increased regulatory approval of medical dilation devices, adoption of minimally invasive surgery, and ongoing research and development activities are driving the global sinus dilation devices market during the forecast period.

The increasing number of novel product launches and the rising research and development will drive market growth.

The global market for sinus dilation devices is primarily driven by the high prevalence of chronic sinusitis and a growing preference for minimally invasive surgeries. Other factors aiding the market growth are favorable reimbursement scenarios growing the healthcare market in emerging economies.

Technological advancements in sinusitis treatments and the benefits of balloon sinus dilation over conventional operations contribute to the global sinus dilation devices market. For instance, in Feb 2022, Medtronic Plc, a healthcare technology company, launched its novel Eustachian tube dilation balloon named NuVent, approved by the U.S. FDA. NuVent helps surgeons deliver appropriate office or outpatient setting treatment. The flexible balloon section can be customized for placement based on a patient's anatomy.

Various funding, novel technological advancements, and the number of the latest, innovative product launches are increasing, leading to the high demand for sinus dilation devices. For instance, in Sep 2021, Acclarent Inc, Johnson & Johnson Medical Device Subsidiary, which designs minimally invasive ENT technologies, launched its AI-powered ENT technology that will simplify surgical planning and, during ENT navigation procedures, will give feedback. This software will use TruPath and TruSeg with the TruDi navigation system and provide efficient image-guided navigation and planning for ENT surgeries such as endoscopic sinus surgery.

The presence of alternatives and high costs associated with sinus dilation devices will hamper the market's growth.

However, high costs associated with sinus dilation device equipment and the low preference for sinus surgical procedures due to sinusitis drugs may hinder market progress. Over-the-counter drugs account for much of the expense yet provide minimal benefit in most patients with chronic sinusitis.

COVID-19 Impact Analysis

The pandemic has negatively impacted global financial expectations, operations and crisis response strategy. The COVID-19 outbreak has severely impacted the healthcare industry. The sinus dilation devices market has experienced huge losses due to COVID, as all the research and clinical trials got affected due to the diversion of attention toward COVID. But now, the market participants are changing their long-term and short-term growth strategies by utilizing the research market and creating cutting-edge items to combat the pandemic. Various initiatives, collaborations and mergers are happening worldwide, boosting the market's growth. For instance, in Jul 2020, Optim LLC, a proprietary endoscopes manufacturer, announced its partnership with MedShare for donating its ENTity Nasopharyngoscopes to under-served communities globally.

Segment Analysis

The balloon sinus dilation devices are expected to grow at the fastest CAGR during the forecast period (2022-2029)

Balloon sinus dilation devices are the highest market holder in the global sinus dilation devices market. Balloon sinus dilation is a procedure in which, under endoscopic visualization, a flexible balloon catheter is inserted into the sinus passages blocked by an ENT surgeon. After the balloon placement, it is inflated to open the sinus cavity. To flush out pus or mucus, they inject a saline solution. This reduces the trauma caused to delicate tissues in the passage. After the drainage of fluid, the patient feels relieved.

The balloon sinus dilation device segment dominates the market due to the demand for these devices and rising global sinusitis infection cases. The growing number of regulatory approvals, technological advancements, product launches, and research/clinical trial studies drive the market's growth. For instance, in May 2022, Dalent Medical, a medical technology company that designs innovative devices for sinus treatment, acquired a new patent in its intellectual property portfolio. This patent protects the Sinusleeve balloon, Dalen's proprietary balloon sinus dilation device for chronic sinusitis treatment.

Geographical Analysis

North America holds the largest market share of the global sinus dilation devices market.

North America dominates the global sinus dilation devices market, primarily attributed to the increase in the prevalence of chronic sinusitis, increase in pharmaceutical establishment across the region and government approvals, increase in adoption of minimally invasive surgical procedures in recent years, and presence of key players in the region are contributing to the growth of sinus dilation devices market. According to the Sinus and Allergy Wellness Centre report 2021, Sinusitis affects approximately 30 million adults, about 11.6% of the adult population in the United States.

Moreover, the growing number of product launches is responsible for the market's growth. Many key developments, technological advancements, collaborations and agreements are taking place in this region. For instance, in Aug 2022, Acclarent Inc, Johnson & Johnson Medical Device Subsidiary, which designs minimally invasive ENT technologies, announced that its TruDi shaver blade, a single-use electromagnetically navigated blade, got clearance from U.S. Food and Drug Administration. TruDi can be used for the removal or incision of tissues or bones in ENT.

Competitive Landscape

The sinus dilation devices market is moderately competitive with local and global companies' presence. Medtronic Plc, Smith and Nephew Plc, Acclarent, Inc., Stryker, Olympus Corporation, Optim LLC, Cook Medical, Summit Health Medical, Dalent Medical, Meril Life Sciences and more. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the market's growth. For instance, in Feb 2022, Olympus, an innovative solution developer for surgical and medical procedures, announced that its single-use sinus debrider system CELERIS received clearance from the U.S. Food and Drug Administration.

Medtronic Inc.:

Overview:

Medtronic plc is a healthcare technology company that develops, manufactures and markets medical devices. It was established in 1949 and is headquartered in Dublin, Ireland. It is operational in around 140 countries, and 90,000 people are employed there.

Product Portfolio:

NuVent EM Sinus Dilation System: NuVent balloon dilation is a targeted system used for balloon sinus surgery with a built-in electromagnetic surgical navigation technology. It provides a different and unique addition to sinus surgery treatment.

Key Development: In May 2022, Medtronic Plc, a healthcare technology company, announced the completion of the acquisition of Intersect ENT. This acquisition will help Medtronic expand its ENT portfolio in sinus procedures for nasal polyps treatment.

The global sinus dilation devices market report would provide access to approximately 40+ market data tables, 45+ figures, and 200 (approximate) pages.

Table of Contents

1. Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The rising novel product launches
      • 4.1.1.2. Increasing research and development
    • 4.1.2. Restraints:
      • 4.1.2.1. Alternatives available in market
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces
  • 5.2. Unmet Needs
  • 5.3. Supply chain Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Product

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 7.1.2. Market Attractiveness Index, By Product
  • 7.2. Balloon Sinus Dilation Devices*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Sinuscopes
  • 7.4. Rhinoscopes
  • 7.5. Handheld Instruments
  • 7.6. Sinus Stents

8. By Procedure Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Type
    • 8.1.2. Market Attractiveness Index, By Procedure Type
  • 8.2. Standalone Sinus Dilation *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Hybrid Sinus Dilation

9. By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Hospitals *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Ambulatory Surgical Centres
  • 9.4. ENT Clinics
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Type
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), End-User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. The U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Type
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), End-User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. The U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Type
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), End-User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Type
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), End-User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Type
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), End-User
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country

11. Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.2. Company Share Analysis
  • 11.3. Product Benchmarking
  • 11.4. List of Key Companies to Watch

12. Company Profiles

  • 12.1. Medtronic Plc
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Smith and Nephew Plc
  • 12.3. Acclarent, Inc.
  • 12.4. Stryker
  • 12.5. Olympus Corporation
  • 12.6. Optim LLC
  • 12.7. Cook Medical
  • 12.8. Summit Health Medical
  • 12.9. Dalent Medical
  • 12.10. Meril Life Sciences

LIST NOT EXHAUSTIVE

13. Global Sinus Dilation Devices Market- DataM

  • 13.1. Appendix
  • 13.2. About Us and Services
  • 13.3. Contact Us